Medicine and Health

Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study

F. Morschhauser, S. Dahiya, et al.

This groundbreaking phase 2 TRANSCEND FL study showcases the remarkable efficacy and safety of lisocabtagene maraleucel (liso-cel) in treating relapsed/refractory follicular lymphoma. With promising overall response and complete response rates noted among high-risk patients, this research conducted by a talented group of authors speaks volumes about advancements in lymphoma therapies.

00:00

Playback language: English

Related Publications

Explore these studies to deepen your understanding of the subject.

Medicine and Health

Author Correction: Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study

F. Morschhauser, S. Dahiya, et al.

Medicine and Health

Risk factors for and pregnancy outcomes after SARS-CoV-2 in pregnancy according to disease severity: A nationwide cohort study with validation of the SARS-CoV-2 diagnosis of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG)

A. J. M. Aabakke, T. G. Petersen, et al.

Health and Fitness

Short-term improvements in diet quality in people newly diagnosed with type 2 diabetes are associated with smoking status, physical activity and body mass index: the 3D case series study

E. Burch, L. T. Williams, et al.

Medicine and Health

Neoadjuvant pembrolizumab, dabrafenib and trametinib in BRAFV600-mutant resectable melanoma: the randomized phase 2 Neo Trio trial

G. V. Long, M. S. Carlino, et al.

Listen, Learn & Level Up

Over 10,000 hours of research content in 25+ fields, available in 12+ languages.

No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.

listen to research audio papers with researchbunny